DOGOページ Inhibikase Therapeutics Announces Advancement of IkT-148009 Phaseの詳細情報
Inhibikase Therapeutics Announces Advancement of IkT-148009 Phase。The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in。Inhibikase Therapeutics Initiates Development of Second Generation。Amazon.com: DOOZX: Dog Grooming Table。商品の説明はありません